Article
The hsa-miR-520a/MYO19 Axis Modulates Tumor Progression and Immune Evasion Through Ferroptosis in Lung Squamous Cell Carcinoma: Insights from Pan-Cancer Analysis
2025-06-24
Abstract excerpt
<title>Abstract</title> <p>Background Lung squamous cell carcinoma (LUSC) is a highly aggressive malignancy with limited therapeutic options and poor clinical outcomes. Recent studies have underscored the critical role of ferroptosis—a regulated form of cell death—in tumor development, immune regulation, and resistance to therapy. MYO19, a mitochondrial trafficking protein, has been implicated in cancer progress...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5a282def-7959-5589-8e96-aa8bcf313f7e
- DOI
- 10.21203/rs.3.rs-6730184/v1
